Back to results
US 2016/0058851 A1Published application
Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness
AssigneeMassachusetts Institute of Technology
InventorKI ANN GOOSENS
Life of this patent
Estimating the term…
Abstract
The invention relates to methods of protecting against chronic stress in a subject and treating stress sensitive disorders in a subject by antagonizing ghrelin or ghrelin receptor.
Claims8
A method of treating a stress-sensitive disorder in a subject exposed to chronic stress comprising administering to the subject a therapeutically effective amount of an agent that inhibits the level or activity of ghrelin or ghrelin receptor.
Dependencies are inferred from the claim text.